Novavax | NVAX - Активы





Активы Изменить Дата
Adma Biologics USD 624.24M 55.56M 2025-12
Agenus USD 226.8M 7.09M 2025-12
AstraZeneca USD 114.07B 382M 2025-12
BioCryst Pharmaceuticals USD 514.16M 67.73M 2025-12
Cassava Sciences USD 118.35M 11.38M 2025-12
Geron USD 570.54M 3.16M 2025-12
GlaxoSmithKline GBP 61.12B 221M 2025-12
MannKind USD 792.18M 297.54M 2025-12
Merck USD 129.55B 12.02B 2025-09
Minerva Neurosciences USD 97.97M 69.88M 2025-12
Moderna USD 12.34B 203M 2025-12
Novartis USD 110.95B 3.66B 2025-12
Novavax USD 1.18B 3.38M 2025-12
Pfizer USD 208.73B 2.64B 2025-09
Sanofi EUR 126.81B 2.99B 2025-12
Sarepta Therapeutics USD 3.35B 143.73M 2025-12
TG Therapeutics USD 1.06B 38.23M 2025-12